2
Registered trials
0
Recruiting
2
Unique sponsors
4
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Platinum compound
2 substances
Macrolide / aminoglycoside
1 substance
Antimetabolite
1 substance
Phase III:
1
Phase II:
1
Phase III
1 trial-
EndedThe University Of Birmingham AcademicIMP not specified
Phase II
1 trial-
EndedIRCCS Istituto Nazionale Tumori Fondazione Pascale AcademicBLEOMYCIN SULFATE; CARBOPLATIN; CISPLATIN; FLUOROURACIL
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| IRCCS Istituto Nazionale Tumori Fondazione Pascale | Academic | 1 | Phase II | 0 |
| The University Of Birmingham | Academic | 1 | Phase III | 0 |
New trials by year
2024
1